Improving Trial Power Through Use of Prognosis-Adjusted End Points

Background and Purpose— The stroke patient population is heterogeneous, leading to wide variation in outcome caused by differences in age, initial severity, and presence of concomitant disease. Setting an identical recovery target for all patients in intervention trials may conceal individually i…